Skip to main content
Premium Trial:

Request an Annual Quote

Squibb Licenses Pangea Computational Tools to Boost Genomics Effort

Premium

OAKLAND, Calif.--Bristol-Myers Squibb has licensed from Pangea Systems here state-of-the-art computational tools that will allow faster and more accurate clustering and alignment of expressed sequence tags (EST's) and full-length sequences within large public and proprietary databases. Pangea said the tools will provide Squibb with accurate molecular information in order to increase the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated for use in the drug discovery process.

"Some of the computational challenges of proteomics, expression profiling, and sequence datamining can be reasonably approached only if we can reduce the complexity and redundancy of large EST databases," commented Wes Cosand, Squibb's director of genomic technology. He called the Pangea tool "an excellent package for performing this task."

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.